EquityZen Growth Technology Fund LLC - Series 370
Raised
$1M
Investors
53
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 370 is a Delaware-domiciled pooled investment vehicle filed by EquityZen Advisors LLC and related entities, raising $1.3M from 53 investors under Rule 506(b) and Section 3(c)(1) exemptions with a $10K minimum investment. This amended filing is part of the EquityZen platform, which operates nearly 1,900 pre-IPO SPV structures to provide secondary market access to private company shares.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption pairing for private secondary market vehicles, with a $10K minimum placing it in the retail-accessible tier. The 53-investor count and $1.3M raise ($24.5K average commitment) reflect typical EquityZen series-level deal structures targeting individual accredited investors rather than institutional capital.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
